Sehn, L. H. Et Al. 2019. Polatuzumab Vedotin Plus Bendamustine with Rituximab in Relapsed/Refractory Diffuse Large B-Cell Lymphoma: Updated Results of a Phase Ib/II Randomized Study. 61st Annual Meeting and Exposition of the American-Society-of-Hematology (ASH) , (Florida, United States Of America).

Sehn, L. H., Matasar, M. J., Flowers, C. R., Kamdar, M., McMillan, A. K., Hertzberg, M., ... Assouline, S.(2019). Polatuzumab Vedotin Plus Bendamustine with Rituximab in Relapsed/Refractory Diffuse Large B-Cell Lymphoma: Updated Results of a Phase Ib/II Randomized Study . 61st Annual Meeting and Exposition of the American-Society-of-Hematology (ASH), Florida, United States Of America

Sehn, Laurie Et Al. "Polatuzumab Vedotin Plus Bendamustine with Rituximab in Relapsed/Refractory Diffuse Large B-Cell Lymphoma: Updated Results of a Phase Ib/II Randomized Study," 61st Annual Meeting and Exposition of the American-Society-of-Hematology (ASH), Florida, United States Of America, 2019

Sehn, Laurie H. Et Al. "Polatuzumab Vedotin Plus Bendamustine with Rituximab in Relapsed/Refractory Diffuse Large B-Cell Lymphoma: Updated Results of a Phase Ib/II Randomized Study." 61st Annual Meeting and Exposition of the American-Society-of-Hematology (ASH) , Florida, United States Of America, 2019

Sehn, L. H. Et Al. (2019) . "Polatuzumab Vedotin Plus Bendamustine with Rituximab in Relapsed/Refractory Diffuse Large B-Cell Lymphoma: Updated Results of a Phase Ib/II Randomized Study." 61st Annual Meeting and Exposition of the American-Society-of-Hematology (ASH) , Florida, United States Of America.

@conferencepaper{conferencepaper, author={Laurie H. Sehn Et Al. }, title={Polatuzumab Vedotin Plus Bendamustine with Rituximab in Relapsed/Refractory Diffuse Large B-Cell Lymphoma: Updated Results of a Phase Ib/II Randomized Study}, congress name={61st Annual Meeting and Exposition of the American-Society-of-Hematology (ASH)}, city={Florida}, country={United States Of America}, year={2019}}